Metabolism of vitamin D3 in human osteoblasts:: Evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D3

被引:191
|
作者
Atkins, Gerald J.
Anderson, Paul H.
Findlay, David M.
Welldon, Katie J.
Vincent, Cristina
Zannettino, Andrew C. W.
O'Loughlin, Peter D.
Morris, Howard A.
机构
[1] Univ Adelaide, Dept Orthopaed & Trauma, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Inst Med & Vet Sci, Div Haematol, Adelaide, SA 5000, Australia
[3] Hanson Inst, Adelaide, SA 5000, Australia
基金
英国医学研究理事会;
关键词
vitamin D; 25-hydroxyvitamin D-3; CYP24; CYP27B1; osteoblasts;
D O I
10.1016/j.bone.2007.02.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Circulating 1 alpha,25-dihydroxyvitamin D-3 (1,25D) derives from renal conversion of 25-hydroxyvitamin D-3 (25D), by the 25D 1 alpha-hydroxylase (CYP27B1). Blood 25D levels, but not 1,25D levels, are the best indicator of vitamin D status and predict fracture risk in the elderly. We examined the extent to which osteoblasts can metabolize 25D. Well-characterized human primary osteoblasts and osteosarcoma (OS) cell lines were examined for the expression and regulation of genes associated with vitamin D metabolism, using real-time PCR. Primary osteoblasts and OS cell lines were found to express CYP27B1 mRNA and secreted detectable 1,25D in response to 25D. Of the OS cell lines tested, HOS expressed the most CYP27B1 mRNA and secreted the highest levels of 1,25D. All osteoblastic cells examined up-regulated expression of the catabolic regulator of 1,25D, the 25-hydroxyvitamin D-24-hydroxylase (CYP24), when incubated with either 1,25D or 25D. Exposure to physiological levels of 25D resulted in up-regulated transcription of the 1,25D responsive genes, osteocalcin (OCN), osteopontin (OPN) and RANKL. Specific knockdown of CYP27B1 in HOS cells using siRNA resulted in up to 80% reduction in both 1,25D secretion and the transcription of OCN and CYP24, strongly implying that the 25D effect in osteoblasts is preceded by conversion to 1,25D. Incubation with 25D, like 1,251), inhibited primary osteoblast proliferation and promoted in vitro mineralization. Finally, we detected expression by osteoblasts of receptors for vitamin D binding protein (DBP), cubilin and megalin, suggesting that osteoblasts are able to internalize DBP-25D complexes in vivo. Together, our results suggest that autocrine, and perhaps paracrine, pathways of vitamin D-3 metabolism may regulate key osteoblast functions independently of circulating, kidney derived 1,25D. Our results are therefore consistent with the reported benefits of maintaining a healthy vitamin D status in the elderly to reduce the risk of fractures. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1517 / 1528
页数:12
相关论文
共 50 条
  • [41] 1ALPHA-HYDROXYVITAMIN D3 - BIOLOGICAL-ACTIVITY AND METABOLISM TO 1ALPHA, 25-DIHYDROXYVITAMIN D3
    ZERWEKH, JE
    CORK, DJ
    BRUMBAUGH, PF
    HAUSSLER, MR
    FEDERATION PROCEEDINGS, 1974, 33 (03) : 679 - 679
  • [42] Expression of nephronectin is enhanced by 1α,25-dihydroxyvitamin D3
    Hiranuma, Katsuhiro
    Yamada, Atsushi
    Kurosawa, Tamaki
    Aizawa, Ryo
    Suzuki, Dai
    Saito, Yoshiro
    Nagahama, Ryo
    Ikehata, Mikiko
    Tsukasaki, Masayuki
    Morimura, Naoko
    Chikazu, Daichi
    Maki, Koutaro
    Shirota, Tatsuo
    Takami, Masamichi
    Yamamoto, Matsuo
    Iijima, Takehiko
    Kamijo, Ryutaro
    FEBS OPEN BIO, 2016, 6 (09): : 914 - 918
  • [43] 1α,25-Dihydroxyvitamin D3-26,23-lactam, a novel vitamin D3 analog, acts as a vitamin D3 antagonist in human prostate cancer cells
    Takita, Morichika
    Hirata, Michiko
    Tsukamoto, Kazuki
    Nagasawa, Kazuo
    Miyaura, Chisato
    Inada, Masaki
    JOURNAL OF HEALTH SCIENCE, 2008, 54 (04) : 497 - 502
  • [44] The Use of 1α,25-Dihydroxyvitamin D3 as an Anticancer Agent
    Marcinkowska, Ewa
    Wallace, Graham R.
    Brown, Geoffrey
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)
  • [45] A novel and practical route to A-ring enyne synthon for 1α,25-dihydroxyvitamin D3 analogs:: Synthesis of A-Ring diastereomers of 1α,25-dihydroxyvitamin D3 AND 2-methyl-1,25-dihydroxyvitamin D3
    Konno, K
    Maki, S
    Fujishima, T
    Liu, ZP
    Miura, D
    Chokki, M
    Takayama, H
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (02) : 151 - 156
  • [46] The collective influence of 1, 25-dihydroxyvitamin D3 with physiological fluid shear stress on osteoblasts
    Li, Yan
    Yuan, Jiafeng
    Wang, Qianwen
    Sun, Lijie
    Sha, Yunying
    Li, Yanxiang
    Wang, Lizhong
    Wang, Zhonghua
    Ma, Yonggang
    Cao, Hui
    STEROIDS, 2018, 129 : 9 - 16
  • [47] Comparison of 26,27-hexafluoro-1α,25-dihydroxyvitamin D3 and 1α,25-dihydroxyvitamin D3 on the resorption of bone explants ex vivo
    Miyahara, T
    Harada, M
    Kozakai, A
    Matsumoto, M
    Hashimoto, K
    Inoue, H
    Yoda, K
    Nakatsu, T
    Kajita, S
    Yamazaki, R
    Higuchi, S
    Kozuka, H
    Nemoto, N
    JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 1999, 45 (03) : 239 - 249
  • [48] 1[alpha],25-dihydroxyvitamin D3 enhances annexin II dependent proliferation of osteoblasts
    Maier, S. M.
    Scherer, S. J.
    Seifert, M.
    Hanselmann, R. G.
    Schleehuber, Y.
    Edelmarl, L.
    Reichrath, J.
    Krohne, G.
    Rescher, U.
    Seidl, W.
    Mutschler, W.
    Claes, L.
    Welter, C.
    Schartl, M.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 100 (03) : 679 - 692
  • [49] Levels of 24,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 and 25-hydroxyvitamin D3 3-sulphate in human plasma
    Higashi, T
    Mitamura, K
    Ohmi, H
    Yamada, N
    Shimada, K
    Tanaka, K
    Honjo, H
    ANNALS OF CLINICAL BIOCHEMISTRY, 1999, 36 : 43 - 47
  • [50] Effects of 1α,25-dihydroxyvitamin D3 in human colon cancer cells
    Gonzalez-Sancho, Jose Manuel
    Larriba, Maria Jesus
    Ordonez-Moran, Paloma
    Palmer, Hector G.
    Munoz, Alberto
    ANTICANCER RESEARCH, 2006, 26 (4A) : 2669 - 2681